
AVDL Valuation
Avadel Pharmaceuticals PLC
- Overview
- Forecast
- Valuation
- Earnings
AVDL Relative Valuation
AVDL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVDL is overvalued; if below, it's undervalued.
Historical Valuation
Avadel Pharmaceuticals PLC (AVDL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.78 is considered Undervalued compared with the five-year average of 162.09. The fair price of Avadel Pharmaceuticals PLC (AVDL) is between 199.88 to 207.93 according to relative valuation methord. Compared to the current price of 11.03 USD , Avadel Pharmaceuticals PLC is Undervalued By 94.48%.
Relative Value
Fair Zone
199.88-207.93
Current Price:11.03
94.48%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
14.39
P/B
Median3y
15.67
Median5y
15.67
-2.38
FCF Yield
Median3y
-7.10
Median5y
-7.10
Competitors Valuation Multiple
The average P/S ratio for AVDL's competitors is 286.74, providing a benchmark for relative valuation. Avadel Pharmaceuticals PLC Corp (AVDL) exhibits a P/S ratio of 3.78, which is -98.68% above the industry average. Given its robust revenue growth of 93.21%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

QURE
Uniqure NV
15.110
USD
-0.66%

CAC
Camden National Corp
41.000
USD
+0.12%

EGBN
Eagle Bancorp Inc
16.250
USD
-4.02%

HOV
Hovnanian Enterprises Inc
120.050
USD
+0.93%

ODP
ODP Corp
18.580
USD
+2.20%

RLAY
Relay Therapeutics Inc
3.740
USD
+1.63%

WRLD
World Acceptance Corp
159.090
USD
+2.75%

VLRS
Controladora Vuela Compania de Aviacion SAB de CV
5.440
USD
+2.26%

MAX
Mediaalpha Inc
10.880
USD
+0.28%

HUYA
HUYA Inc
3.540
USD
-3.54%
FAQ

Is Avadel Pharmaceuticals PLC (AVDL) currently overvalued or undervalued?
Avadel Pharmaceuticals PLC (AVDL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.78 is considered Undervalued compared with the five-year average of 162.09. The fair price of Avadel Pharmaceuticals PLC (AVDL) is between 199.88 to 207.93 according to relative valuation methord. Compared to the current price of 11.03 USD , Avadel Pharmaceuticals PLC is Undervalued By 94.48% .

What is Avadel Pharmaceuticals PLC (AVDL) fair value?

How does AVDL's valuation metrics compare to the industry average?

What is the current P/B ratio for Avadel Pharmaceuticals PLC (AVDL) as of Jul 27 2025?

What is the current FCF Yield for Avadel Pharmaceuticals PLC (AVDL) as of Jul 27 2025?

What is the current Forward P/E ratio for Avadel Pharmaceuticals PLC (AVDL) as of Jul 27 2025?
